FMC reports Q3 adjusted EPS 89c, consensus 85c

Reports Q3 revenue $542M, consensus $1.06B. Revenue of $542M, down 49% versus Q3 2024, impacted by significant one-time commercial actions taken in India to position the business for sale. “Third quarter sales were down 49 percent versus prior year largely due to India actions. However, on a like-for-like basis, sales were down 4 percent, excluding India in both periods” said Pierre Brondeau, chairman and chief executive officer. “Our results reflect the challenges we’re facing, most prominently in Latin America. Despite this, our new active ingredients nearly doubled in the quarter and remain central to our strategy.”